SCHEMBL19081007

SCHEMBL19081007

CC1(C)c2cc(-c3c4ccccc4c(-c4ccc5c(c4)oc4ccccc45)c4ccccc34)ccc2-c2ccc3c(oc4c5ccccc5ccc34)c21

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.35
ABCB1 P08183 4/20 0.35
ABCC1 P33527 4/20 0.35
PRKDC P78527 2/20 0.34
ALOX5 P09917 1/20 0.34
ARSA P15289 1/20 0.34
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
CYP1A1 P04798 7/20 0.33
CYP1B1 Q16678 7/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 6/20 0.33
DUSP3 P51452 1/20 0.33
PSMD14 O00487 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
XDH P47989 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24285522 0.91 DUSP3 (0.35) PRKDCALOX5KMT2ADUSP3TDP1
SCHEMBL19081000 0.88 ARSA (0.36) ABCG2ABCB1ABCC1PRKDCARSA
SCHEMBL19080810 0.87 CYP1A1 (0.38) ABCG2ABCB1ABCC1PRKDCARSA
SCHEMBL19080863 0.86 CYP1A1 (0.41) ABCG2ABCB1ABCC1PRKDCARSA
SCHEMBL19080757 0.86 CYP1A1 (0.38) ABCG2ABCB1ABCC1PRKDCARSA
SCHEMBL20127518 0.86 ARSA (0.36) ABCG2ABCB1ABCC1PRKDCARSA
SCHEMBL17944723 0.85 ALOX5 (0.36) PRKDCALOX5CYP1A1CYP1B1KMT2A
SCHEMBL17945187 0.85 PRKDC (0.34) ABCG2ABCB1ABCC1PRKDCALOX5
SCHEMBL19080842 0.85 CYP1A1 (0.34) ABCG2ABCB1ABCC1PRKDCARSA
SCHEMBL19081009 0.85 ALOX5 (0.33) ABCG2ABCB1ABCC1PRKDCALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885ABCB1 3875/4885ABCC1 3301/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885ABCB1 3875/4885ABCC1 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.